Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Foghorn Therapeutics
FHTX
$323M
| $556K | ﹤0.01% |
118,342
+15,454
| +15% | +$64.6K |
|
1702
Blue Owl Capital
OWL
$7.7B
| $551K | ﹤0.01% |
28,670
+7,293
| +34% | +$135K |
|
|
MASI
1703
DELISTED
Masimo
MASI
| $549K | ﹤0.01% |
3,266
+1,969
| +152% | +$314K |
|
|
DVAX
1704
DELISTED
Dynavax Technologies
DVAX
| $538K | ﹤0.01% |
54,271
-2,445
| -4% | -$25.8K |
|
1705
Elbit Systems
ESLT
$40.4B
| $534K | ﹤0.01% |
+1,200
| New | +$487K |
|
1706
Amneal Pharmaceuticals
AMRX
$5.77B
| $531K | ﹤0.01% |
65,617
-4,435
| -6% | -$33.4K |
|
1707
Biohaven
BHVN
$2.15B
| $529K | ﹤0.01% |
37,459
-765,272
| -95% | -$13.6M |
|
1708
BBB Foods
TBBB
$4.92B
| $521K | ﹤0.01% |
+18,767
| New | +$528K |
|
1709
Travere Therapeutics
TVTX
$6.02B
| $518K | ﹤0.01% |
35,009
+1,839
| +6% | +$30.5K |
|
1710
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $515K | ﹤0.01% |
6,359
-693,805
| -99% | -$56.3M |
|
1711
ANI Pharmaceuticals
ANIP
$1.86B
| $514K | ﹤0.01% |
7,881
-325
| -4% | -$21.2K |
|
1712
LiveRamp
RAMP
$2.3B
| $511K | ﹤0.01% |
15,462
-15,844
| -51% | -$460K |
|
1713
PUT
Palantir
PLTR
$375B
| $503K | ﹤0.01% |
+1,099
| New | +$129K |
|
|
EU
1714
enCore Energy
EU
$225M
| $500K | ﹤0.01% |
174,946
+149,798
| +596% | +$269K |
|
1715
Harmony Biosciences
HRMY
$2.24B
| $497K | ﹤0.01% |
15,732
-625
| -4% | -$20.1K |
|
1716
Omeros
OMER
$930M
| $490K | ﹤0.01% |
163,413
+27,411
| +20% | +$137K |
|
1717
Kohl's
KSS
$2.15B
| $487K | ﹤0.01% |
57,430
+14,635
| +34% | +$113K |
|
1718
Recursion Pharmaceuticals
RXRX
$1.66B
| $481K | ﹤0.01% |
94,982
-12,494
| -12% | -$61.4K |
|
1719
Choiceone Financial
COFS
$510M
| $477K | ﹤0.01% |
16,605
| – | – |
|
1720
iShares Global Energy ETF
IXC
$2.78B
| $471K | ﹤0.01% |
11,979
-12,059
| -50% | -$462K |
|
1721
Aurinia Pharmaceuticals
AUPH
$2.06B
| $468K | ﹤0.01% |
55,217
+27
| +0% | +$216 |
|
1722
Vail Resorts
MTN
$5.28B
| $462K | ﹤0.01% |
2,942
+548
| +23% | +$81.4K |
|
1723
Lexicon Pharmaceuticals
LXRX
$1.07B
| $460K | ﹤0.01% |
+486,674
| New | +$315K |
|
1724
Innoviva
INVA
$1.55B
| $459K | ﹤0.01% |
22,862
-1,535
| -6% | -$29.5K |
|
|
PPLI
1725
People Inc
PPLI
$3.2B
| $459K | ﹤0.01% |
12,292
+559
| +5% | +$20.2K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.